First Patient Enrolled In Clinical Registry Assessing Boston Scientific Verciseâ„¢ Deep Brain Stimulation System In Patients With Parkinson’s Disease

[PR Newswire] – NATICK, Mass., April 10, 2014 /PRNewswire/ — Boston Scientific Corporation (BSX) has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Verciseâ„¢ Deep Brain Stimulation (DBS) System more

View todays social media effects on BSX

View the latest stocks trending across Twitter. Click to view dashboard

See who Boston is hiring next, click here to view